In an adult who suddenly develops small light‑brown facial spots, what is the appropriate evaluation and management?

Evaluation and Management of Sudden-Onset Light-Brown Facial Spots in Adults

In adults who suddenly develop small light-brown facial spots, perform a full-thickness excisional biopsy with 1-3mm margins if melanoma is suspected based on clinical examination and dermoscopy; otherwise, most cases represent benign hyperpigmentation (melasma, solar lentigines, or self-limited conditions) that can be managed conservatively with photoprotection and observation.

Initial Clinical Assessment

The critical first step is distinguishing potentially malignant lesions from benign hyperpigmentation:

Red Flags Requiring Biopsy (Melanoma Concern)

Examine for the "ABCD" criteria and "ugly duckling" sign 1:

• Asymmetry in shape
• Border irregularities
• Color heterogeneity (multiple shades within lesion)
• Dynamics/Evolution - rapid changes in color, elevation, or size

Important caveat: Many early melanomas are now <5mm in diameter, so size alone should not provide false reassurance 1. The evolution/dynamics criterion is particularly important for identifying rapidly growing amelanotic melanomas 1.

Dermoscopy Enhancement

Dermoscopy by an experienced physician significantly improves diagnostic accuracy and should be performed when available 1. This is particularly valuable for distinguishing lentigo maligna from pigmented actinic keratosis and solar lentigines on sun-damaged facial skin 2.

Biopsy Technique When Melanoma Suspected

If clinical concern exists, perform complete/excisional biopsy with narrow 1-3mm margins around the lesion 3. This can be:

• Full thickness (fusiform/elliptical, disk, or punch)
• Shave removal into deep reticular dermis via saucerization technique 3

Complete biopsy is essential to maximize histopathologic examination and accurate microstaging 3.

Benign Hyperpigmentation Management

For lesions without melanoma features, the differential includes:

Most Common Diagnoses in Adults

1. Melasma - symmetrical brown patches, often hormonally influenced 4
2. Solar lentigines - discrete brown macules on sun-exposed areas
3. Post-inflammatory hyperpigmentation
4. Acquired facial hyperpigmented macules (AFHM) - though more common in children, can occur in young adults 5

Systematic Evaluation Approach

History to obtain:

• Timeline of onset (truly sudden vs. gradual recognition)
• Sun exposure patterns
• Hormonal factors (pregnancy, oral contraceptives, hormone therapy)
• Medications (photosensitizing drugs)
• Cosmetic/perfume use 6
• Systemic symptoms suggesting Addison's disease (fatigue, weight loss, hypotension) 7, 8

Physical examination specifics:

• Distribution pattern (symmetrical suggests melasma; unilateral suggests other causes)
• Associated findings (telangiectasias, skin texture changes)
• Oral mucosa examination (pigmentation suggests Addison's disease) 8
• Other body sites (hands, skin folds for Addison's) 7

Conservative Management Strategy

For confirmed benign hyperpigmentation:

Primary intervention - Photoprotection:

• Broad-spectrum sunscreen (mandatory baseline intervention) 6
• Physical sun protection with clothing 1
• Avoidance of UV lamps 6

Topical depigmenting agents for epidermal hyperpigmentation:

• Hydroquinone 2-4% is gold-standard treatment 9, 6
• Can combine with tretinoin 0.05-0.1% for enhanced efficacy 6
• Alternative: Azelaic acid 15-20% (less irritating than hydroquinone) 6
• Kojic acid with glycolic acid or hydroquinone 6

Observation for self-limited conditions:

• AFHM typically resolves spontaneously over 31-67 months with >96% complete clearance 5
• If lesions show improvement over time, continue conservative management

Critical Pitfalls to Avoid

1. Missing lentigo maligna: Pigmented facial macules on chronically sun-damaged skin are diagnostically challenging with overlapping dermoscopic features between benign and malignant lesions 2. When in doubt, biopsy.

2. Overlooking systemic disease: Always consider and exclude Addison's disease in clinically relevant cases, especially with progressive pigmentation involving mucosa and other body sites 7, 8.

3. Premature laser treatment: Dermal hyperpigmentation is challenging to treat topically 9, and laser therapy for melasma has shown unsatisfactory results with risk of inducing further hyperpigmentation and recurrence 6. Reserve for refractory cases after conservative management fails.

4. Inadequate photoprotection: Treatment failure most commonly results from continued UV exposure without adequate sun protection 6, 10.